Articles Tagged With: treatment
-
Quinacrine for Refractory Giardiasis
Quinacrine is highly effective in the treatment of giardiasis that is recalcitrant to initial therapy with other agents, but patients must be warned about neuropsychiatric effects. -
Treatment, Research Centers Trying to Solve Long COVID-19
Lingering COVID-19 symptoms in many patients may be the last and most insidious wave of the pandemic, since people who have been infected experience a prolonged, sometimes changing array of ill effects. The concern is that a subset of these cases will develop a kind of chronic COVID-19 that becomes a lifelong condition.
-
Sepsis Report Could Help ED Malpractice Defense
Of the many different guidelines on early sepsis care in the ED, some specific recommendations remain controversial. A recently released report addresses many of these issues. -
40 years of HIV: From Fear and Stigma to Effective Treatment
A constantly mutating retrovirus that attacks the immune system directly, human immunodeficiency virus was isolated as the cause of acquired immunodeficiency syndrome in 1984. There was initial optimism that a vaccine would be forthcoming, but it was not to be.
-
U.S. Slips in Blood Pressure Management
After years of improvement in this area, investigators recently observed troubling decline in rate control. -
HHS Expands Mental Health Services Access for Young Patients
Agency designates funding for existing program that promotes behavioral health integration into pediatric primary care using telehealth. -
Use State-Level Policy to Drive Rapid Changes in Opioid Use Disorder Treatment
Recognizing that EDs are uniquely positioned to engage patients with opioid use disorder into effective treatment, Pennsylvania officials decided to test whether financial incentives would be enough to nudge hospitals to facilitate stronger action.
-
Lung Health Program Revamped to Help Manage COVID-19 Pandemic
A Maryland hospital adapted an existing program encouraging lung health to respond to the sudden demands of COVID-19. The program helped reduce COVID-19 readmission rates by two-thirds.
-
Polyradiculoneuropathy from Immune Checkpoint Inhibitors
Immune checkpoint inhibitors have become an important part of the armamentarium for the medical treatment of cancers such as melanoma and lung carcinomas. A number of immune-mediated neurological complications have been identified during the use of these agents, including polyradiculoneuropathy.
-
Prednisone vs. Placebo in Short-Term Prevention of Episodic Cluster Headaches
Prednisone, given at 100 mg for five days and then tapering by 20 mg every three days, is a safe and effective short-term prevention for episodic cluster headaches while waiting for longer-acting preventive agents to be initiated.